Hatch Waxman and the FDA: Effect of the 2003 Medicare Modernization act on the FDA's decisions concerning 30-month stays and 180-day exclusivities in ANDA litigation

Denise Main

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com